Advertisement

Is Fever Beneficial?

  • A. Sahib El-Radhi
Chapter

Abstract

  • Fever has a long evolutionary history, which by itself supports the hypothesis that fever is an adaptive host response to infection.

  • There is considerable evidence that fever promotes host defence against infection.

  • Complications and mortality associated with high fever >40 °C are closely related to the severity of the underlying disease, not to the level of fever.

  • Fever is effectively controlled by the hypothalamic centre and therefore does not climb up relentlessly. Temperatures >42 °C are often caused by hyperthermia, not by fever.

  • If the febrile child is comfortable, there is little reason to support the practice of routine use of antipyretic medication.

  • Parental education is critical in the management of the febrile child.

  • Antipyretics do not prevent febrile seizures.

  • There is a conflict between research evidence supporting a positive role of fever and the demands of current practice that fever be abolished.

Keywords

Benefits and harms of fever Effects of fever on microorganisms Risk of febrile seizures Hygiene theory 

References

  1. 1.
    Kluger MJ, Kozak W, Mayfield KP. Fever and immunity. In:Psychoneuroimmunology, vol. I. 3rd ed. Cambridge: Academic Press; 2001. p. 687–702.Google Scholar
  2. 2.
    Osawa E, Muschel LH. Studies relating to the serum resistance of certain gram-negative bacteria. J Exp Med. 1964;119:41–51.CrossRefGoogle Scholar
  3. 3.
    Lwoff A. Factors influencing the evolution of viral diseases of the cellular level and in the organism. Bacteriol Rev. 1959;23:109–24.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Yerushalmi A, Lwoff A. Traitment du coryza infectieux et des rhinitis persistantes allergiques par la thermotherapie. Comp Rendus Seances Acad Sci. 1980;291:957–9.Google Scholar
  5. 5.
    Vk W, Hitchcock W, Mason WH. Meningococcal infections in children: a review of 100 cases. Pediatr Infect Dis J. 1989;8:224–7.Google Scholar
  6. 6.
    El-Radhi AS, Rostila T, Vesikari T. Association of high fever and short bacterial excretion after salmonellosis. Arch Dis Child. 1992;67:81.CrossRefGoogle Scholar
  7. 7.
    Nahas GG, Tannieres ML, Lennon JF. Direct measurement of leukocyte motility: effects of pH and temperature. Proc Soc Exp Biol Med. 1971;138:350–2.CrossRefGoogle Scholar
  8. 8.
    Duff GW, Durum SK. Fever and immunoregulation: hyperthermia, interleukin 1 and 2, and T-cell proliferation. Yale J Biol Med. 1982;55:437–42.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Murphy PA, Hanson DF, Guo YN, Angster DE. The effects of variations in pH and temperature on the activation of mouse thymocytes by both forms of rabbit interleukin-1. Yale J Biol Med. 1985;58:115–23.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Dinarello CA, Bernstein HA, Duff GW, Le HV, Naqabhushan TL, Hamilton CC, Coceani F. Mechanisms of fever induced by recombinant human interferon. J Clin Invest. 1984;74:906–13.CrossRefGoogle Scholar
  11. 11.
    Heron I, Berg K, Cantel K. Regulatory effect of interferon on T cell in vitro. J Immunol. 1976;17:1370–3.Google Scholar
  12. 12.
    Mackowiak PA, Marling-Cason M, Cohen RL. Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis. 1982;145:550–3.CrossRefGoogle Scholar
  13. 13.
    Donato V, Zurlo A, Nappa M, Capua A, Banelli E, Martelli M, Babriele P, Amichetti M, Biagini C. Multicentre experience with combined hyperthermia and radiation therapy in the treatment of superficially located non-Hodgkin’s lymphomas. J Exp Clin Cancer Res. 1997;16:87–90.PubMedGoogle Scholar
  14. 14.
    Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science. 1975;188:166–8.CrossRefGoogle Scholar
  15. 15.
    Bernheim HA, Kluger MJ. Fever: of drug-induced antipyresis on survival. Science. 1976;193:237–9.CrossRefGoogle Scholar
  16. 16.
    Graham NH, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding and clinical status in rhinovirus-infected volunteers. Infect Dis. 1990;162:1277–82.CrossRefGoogle Scholar
  17. 17.
    Doran TF, Angelis CD, Baumgarder RA, et al. Acetaminophen: more harm than good in chickenpox? J Pediatr. 1989;114:1045–8.CrossRefGoogle Scholar
  18. 18.
    Sugimura T, Fujimoto T, Motoyama T, et al. Risks of antipyretics in young children with fever due to infectious diseases. Acta Paediatr Jpn. 1994;36:375–8.CrossRefGoogle Scholar
  19. 19.
    Earn DJ, Andrews PW, Bolker BM. Population-level effects of suppressing fever. Proc Biol Sci. 2014;281(1778):20132570.CrossRefGoogle Scholar
  20. 20.
    Muschenheim C, Duerschrer DR, Hardy JD, et al. Hypothermia in experimental infections. Infect Dis. 1943;72:187–96.CrossRefGoogle Scholar
  21. 21.
    Husseini RH, Sweet C, Collie MH, et al. Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. Infect Dis. 1982;145:520–4.CrossRefGoogle Scholar
  22. 22.
    El-Radhi AS, Jawad MJ, Mansor N, et al. Infection in neonatal hypothermia. Arch Dis Child. 1983;58:143–5.CrossRefGoogle Scholar
  23. 23.
    Williams LK, Peterson EL, Ownby DR, Johnson CC. The relationship between early fever and allergic sensitization at age 6 to 7 years. J Allergy Clin Immunol. 2004;113:291–6.CrossRefGoogle Scholar
  24. 24.
    Custovic A. The hygiene hypothesis revisited: pros and cons. Asthma and immunology 60th anniversary meeting March 7–12, 2003.Google Scholar
  25. 25.
    Albonico HU, Braker HU, Husler J. Febrile infectious childhood disease in the history of cancer patients and matched control. Med Hypotheses. 1998;51:315–20.CrossRefGoogle Scholar
  26. 26.
    Schmitt BD. Fever phobia. Am J Dis Child. 1980;134:176–81.CrossRefGoogle Scholar
  27. 27.
    May A, Bauchner H. Fever phobia: the pediatrician’s contribution. Pediatrics. 1992;90:851–4.PubMedGoogle Scholar
  28. 28.
    Ekholm E, Niemineva K. On convulsions in early childhood and their prognosis. Acta Paediatr. 1950;39:481–501.CrossRefGoogle Scholar
  29. 29.
    Rosman NP. Febrile convulsions. In: Mackowiak PA, editor. Fever: basic mechanisms and management. 2nd ed. Philadelphia: Lippinocott-Raven Publishers; 1997. p. 267–77.Google Scholar
  30. 30.
    Kramer MS, Naimark L, Leduc DG, et al. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet. 1991;337:591–4.CrossRefGoogle Scholar
  31. 31.
    El-Radhi AS, Barry W. Do antipyretics prevent febrile convulsions? Arch Dis Child. 2003;88:641–2.CrossRefGoogle Scholar
  32. 32.
    Schnaiderman D, Lahat E, Sheefer T, Aladjem M. Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage. Eur J Pediatr. 1993;152:747–9.CrossRefGoogle Scholar
  33. 33.
    Van Stuijvenberg M, Derksen-Lubsen G, Steyerberg EW, et al. Randomized, controlled trial of ibuprofen syrup administered during febrile illnesses to prevent febrile recurrences. Pediatrics. 1998;102:1–7.CrossRefGoogle Scholar
  34. 34.
    Van Esch A, Steyerberg EW, Moll HA, et al. A study of the efficacy of antipyretic drugs in the prevention of febrile seizure recurrence. Ambulatory Child Health. 2000;6:19–26.CrossRefGoogle Scholar
  35. 35.
    Meremikwu M, Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Database Syst Rev. 2002;4:CD003676.Google Scholar
  36. 36.
    El-Radhi AS. Lower degree of fever is associated with increased risk of subsequent convulsions. Europ J Paediatr Neurol. 1998;2:91–6.CrossRefGoogle Scholar
  37. 37.
    Offringa M, Derksen-Lubsen G, Bossuyt P. Seizure recurrence after a first febrile seizure: a multivariate approach. Dev Med Child Neurol. 1992;34:15–24.CrossRefGoogle Scholar
  38. 38.
    Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, D’Allessandro R. Fever in acute stroke worsens prognosis. Stroke. 1995;26:2040–3.CrossRefGoogle Scholar
  39. 39.
    Kammersgaard LP, Jorgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, Houth J, Olsen TS. Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke. 2002;33:1759–62.CrossRefGoogle Scholar
  40. 40.
    Pollheimer J, Zellner M, Eliasen MM, Roth E, Oehler R. Increased susceptibility of glutamine-depleted monocytes to fever-range hyperthermia: the role of 70-kDa heat shock protein. Ann Surg. 2005;241:349–55.CrossRefGoogle Scholar
  41. 41.
    Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002;30:2022–9.CrossRefGoogle Scholar
  42. 42.
    El-Radhi AS, Barry W, Patel S. Association of fever and severe clinical course in bronchiolitis. Arch Dis Child. 1999;81:231–4.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • A. Sahib El-Radhi
    • 1
  1. 1.Chelsfield Park HospitalOrpingtonUK

Personalised recommendations